Have a personal or library account? Click to login
The effectiveness of dexamethasone as a combination therapy for COVID-19 Cover

The effectiveness of dexamethasone as a combination therapy for COVID-19

Acta Pharmaceutica
Volume 72 (2022): Issue 3 (September 2022)
By: Nader Namazi  
Open Access
|Apr 2022

Authors

Nader Namazi

nnamazi@taibahu.edu.sa

Pharmaceutics and Pharmaceutical Technology Department College of Pharmacy, Taibah University Al Madinah, Al Munawarah, Saudi Arabia
DOI: https://doi.org/10.2478/acph-2022-0030 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 345 - 358
Accepted on: Jan 28, 2022
|
Published on: Apr 13, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
dexamethasone,
glucocorticosteroids,
acute respiratory distress syndrome,
Coronavirus disease 2019,
combination therapy,
SARS-CoV-2,
immunosuppressive
Related subjects:
Pharmacy,
Pharmacy, other

© 2022 Nader Namazi, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 72 (2022): Issue 3 (September 2022)Next article